organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 91³Ô¹Ï Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
91³Ô¹Ï Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Articles published in Journal of Alzheimers Disease & Parkinsonism have been cited by esteemed scholars and scientists all around the world. Journal of Alzheimers Disease & Parkinsonism has got h-index 25, which means every article in Journal of Alzheimers Disease & Parkinsonism has got 25 average citations.
Following are the list of articles that have cited the articles published in Journal of Alzheimers Disease & Parkinsonism.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|---|
Total published articles |
26 | 33 | 60 | 35 | 45 | 44 | 107 | 89 |
Conference proceedings |
0 | 33 | 0 | 0 | 82 | 213 | 118 | 158 |
Citations received as per Google Scholar, other indexing platforms and portals |
123 | 389 | 489 | 425 | 374 | 263 | 237 | 253 |
Journal total citations count | 4334 |
Journal impact factor | 2.04 |
Journal 5 years impact factor | 3.14 |
Journal cite score | 10.01 |
Journal h-index | 25 |
Journal h-index since 2019 | 22 |
![]() |
Molecular pathogenesis and interventional strategies for Alzheimer's disease: promises and pitfalls |
| | | |
![]() |
Significance of blood and cerebrospinal fluid biomarkers for Alzheimer's disease: sensitivity, specificity and potential for clinical use |
| | | |
![]() |
A young-onset frontal dementia with dramatic calcifications due to a novel CSF1R mutation |
| | | |
![]() |
Dietary arachidonic acid increases deleterious effects of amyloid-? oligomers on learning abilities and expression of AMPA receptors: putative role of the ACSL4-cPLA2 balance |
| | | |
![]() |
Regulation of microRNAs-mediated autophagic flux: a new regulatory avenue for neurodegenerative diseases with focus on prion diseases |
| | | |
![]() |
The role of retromer in Alzheimer's disease |
| | | |
![]() |
Evidence of CNS ?-amyloid deposition in Nasu-Hakola disease due to the TREM2 Q33X mutation |
| | | |
![]() |
Soluble TREM2 and biomarkers of central and peripheral inflammation in neurodegenerative disease |
| | | |
![]() |
Over-expressed pathogenic miRNAs in Alzheimer's disease (AD) and prion disease (PrD) drive deficits in TREM2-mediated A?42 peptide clearance |
| | | |
![]() |
microRNA-based biomarkers and the diagnosis of Alzheimer's disease |
| | | |
![]() |
The glycosylated flavonoids vitexin, isovitexin, and quercetrin isolated from Serjania erecta Radlk (Sapindaceae) leaves protect PC12 cells against amyloid-?25-35 peptide-induced toxicity |
| | | |
![]() |
Alcohol and Alzheimer's Disease—Does Alcohol Dependence Contribute to Beta-Amyloid Deposition, Neuroinflammation and Neurodegeneration in Alzheimer's Disease? |
| | | |
![]() |
Brain region-specific enhancement of remyelination and prevention of demyelination by the CSF1R kinase inhibitor BLZ945 |
| | | |
![]() |
Developing therapeutic vaccines against Alzheimer's disease |
| | | |
![]() |
The effect of increased genetic risk for Alzheimer's disease on hippocampal and amygdala volume |
| | | |
![]() |
Lymphatic drainage system of the brain: a novel target for intervention of neurological diseases |
| | | |
![]() |
Imaging robust microglial activation after lipopolysaccharide administration in humans with PET |
| | | |
![]() |
Stem Cell Research Therapy for Neurodegenerative Disorders- In What Way to Make it Work |
| | | |
![]() |
Cancer-Related Reprogramming of Human by Tumor Suppressor Gene |
| | | |
![]() |
Depression: A Scientific Approach |
| | | |
Make the best use of Scientific Research and information from our 700 + peer reviewed, 91³Ô¹Ï Journals